About Mary Kate Wold
Form D filings for Nucleus Radiopharma in 2024 list Mary Kate Wold as director.
Mary Kate Wold first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Mary Kate Wold in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Mary Kate Wold works with at each company, as listed on that company's latest Form D.
Nucleus Radiopharma, Inc. · Form D, Apr 11, 2024
CC
Charles Conroy
Chief Executive Officer and director
JB
Justin Butler
Director
MN
Manu Nair
Director
TR
Tyrell Rivers
Director
NS
Norman Sharpless
Director
MR
Michael Rossi
Director
CM
Chris McDonald
Director